Measurements of the coefficient of variation of the nuclear localized GFP-TR$ were done essentially as described previously (27) with the following modifications. Data analysis was performed on a Gateway E-5200 with Scion Image (Scioncorp, Frederick MD). For each cell, a minimum of 7 line profiles were generated and for each condition, a minimum of 10 cells were analyzed from two independent experiments.
Heterokaryon analysis
Heterokaryon analysis was performed as described previously (28). Briefly, 2X10 5 mouse cells (NIH3T3) were plated on glass coverslips in a 6-well dish. The following day, the cells were transfected with 1 mg of pEGFP-TR$ as described above. After 48 hours, 1X10 6 human cells (HeLa) were plated on the same coverslips. Following a 3 hour incubation, the cells were washed thoroughly with PBS and treated with 100 ml of warmed PEG1500. 2 hours later the cells were washed again with PBS and incubated with DMEM with 50 mg/ ml of cycloheximide for 3 hours, fixed with 4% paraformaldehyde, stained with DAPI (to visualize chromatin) and mounted on glass slides. Cells were imaged by confocal microscopy as described above.
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Results
To study the intracellular distribution of TR$ in living cells, we generated a GFP fusion to the N-terminus of wild-type TR$ (GFP-TR$; Fig. 1A ). In addition, GFP fusions were made to a series of TR$ mutants (Fig. 1B) . GFP-TR$-AHT contains three point mutations in the hinge region (A223G, H224G and T227G) which abrogate its interaction with the nuclear co-repressor N-CoR (32) . GFP-TR$-127 contains a mutation within the DNA-binding domain (C127A) that destroys the integrity of the first zinc finger and prevents the receptor from binding DNA in vitro (33) . GFP-TR$-429 (R429Q) and GFP-TR$-345 (G345R) are natural mutants from patients with resistance to thyroid hormone and are deficient in homodimerization and ligand-binding respectively (33) . Western blot analysis indicated that all GFP fusion constructs generated proteins of the predicted size (data not shown). In addition, the transcriptional activity of each GFP-fusion was assayed in transient co-transfection studies, and found to be similar to that reported previously for the unfused receptors (data not shown).
Analysis of the intracellular distribution of GFP-TR$ in living cells demonstrated that the majority of TR$ localized within the nucleus in both the absence and presence of T 3 ( Figs. 2A-B) .
To quantitate the percentage of GFP-TR$ present within the nucleus, the area-corrected intensity of GFP-TR$ fluorescence in both the nucleus and the cytoplasm was calculated (see Materials and Methods). From these analyses, we determined that 85-90% of GFP-TR$ was localized within the nucleus in both the absence and presence of T 3 (Figs. 2A-B, Table 1 ). In addition, GFP-TR$ was excluded from the nucleoli, as has been reported for other nuclear receptors [Figs.
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DNA transfected, indicating that protein expression levels did not impact on the observed intracellular distribution of GFP-TR$ (data not shown). We found a somewhat lower cytoplasmic concentration of TR$ in hormone-free cells than that reported by Zhu et al. 1998 (nuclear/cytoplasmic=1.5 or ~60% nuclear); in the presence of ligand, our results are in complete accord. The quantitative difference in the amount of unliganded receptor in the cytoplasm may be due to differences in experimental conditions between our studies and that of Zhu et al. 1998 .
In previous studies on the intranuclear distribution of other nuclear receptors, such as the estrogen receptor, addition of ligand led to an intranuclear rearrangement of the receptor (27, 34) .
Similarly, upon T 3 addition, an intranuclear rearrangement of GFP-TR$ occurred. In the absence of T 3 , GFP-TR$ was organized in a diffuse, reticular pattern ( Fig. 2A ). Upon addition of T 3 , GFP-TR$ redistributed into a discrete punctate pattern (Fig. 2B) . To quantitate the intranuclear distribution of GFP-TR$ in the absence and presence of T 3 , we adopted the method of . Briefly, the average intensity of GFP-TR$ along a random linear line was determined.
Dividing the standard deviation of the average intensity by the average intensity yielded the coefficient of variation: an intensity corrected value representing the range of GFP-TR$ intensities along a defined line. A low coefficient of variation, indicative of a more diffuse distribution, would be represented by a relatively smooth line profile, as shown in figure 2C . A high coefficient of variation would indicate a more focal distribution and is represented by uneven line profile (Fig. 2D ). In the absence of ligand, the coefficient of variation for GFP-TR$ was 0.11 +/-0.01, whereas in the presence of T 3 , the coefficient of variation increased to 0.25 +/-0.07. Therefore, GFP-TR$ undergoes a quantitative intranuclear redistribution upon the addition of T 3 .
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We then examined the intracellular distribution of the TR$ mutants described above.
GFP-TR$-345, which binds ligand poorly, exhibited a similar intracellular distribution as To investigate if additional factors were required for retaining TR$ within the nucleus, the intracellular distribution of GFP-TR$-429 was studied. GFP-TR$-429 selectively forms heterodimers with the retinoid X receptor (RXR) and is defective in homodimerization. In the 13 absence of ligand, GFP-TR$-429 was ~75% nuclear (Fig. 5A, Table 1 ), similar to that seen with GFP-TR$-127 (Fig. 3C , Table 1 ). However, in the presence of T 3 , GFP-TR$-429 translocated to the nucleus and adopted an intracellular distribution that was indistinguishable from wild-type TR$ (Fig. 5B ). These results demonstrate that homodimerization has only a minor role in maintaining unliganded TR$ within the nucleus and is not required for the nuclear localization of liganded TR$.
To further investigate whether heterodimerization played a role in the nuclear localization of the unliganded TR$ we expressed unfused RXR in the presence of GFP-TR$-AHT, which was mostly cytoplasmic in the absence of ligand. If RXR was involved in the nuclear retention of the receptor, we predicted that co-expression of RXR should increase the nuclear localization of the predominately cytoplasmic GFP-TR$-AHT. Figure 4C demonstrates that this was indeed the case as GFP-TR$-AHT localized to the nucleus when cotransfected with RXR. In addition, as the amount of RXR expression vector transfected into the cell was increased, the amount of GFP-TR$-AHT retained within the nucleus also increased ( Table 2) . As expected, GFP-RXR was found almost completely in the nucleus in both the absence and presence of its ligand, 9-cis-retinoic acid (9C-RA; Figs. 5C-D). Co-expression of N-CoR with GFP-TR$-AHT had no effect on the intracellular distribution of this mutant (Fig. 4D , Table 2 ) as would be predicted by the inability of GFP-TR$-AHT to interact with N-CoR. In addition, co-expressing unfused TR$ had no effect on the intracellular distribution of GFP-TR$-AHT ( 14 Previous studies by Milgrom and associates have shown that both the estrogen and progesterone receptors are actively transported into the nucleus and return to the cytoplasm by passive diffusion (29) . Our studies with GFP-TR$-AHT and RXR suggest that, at least a portion of the intracellular TR$ may also shuttle between the nucleus and the cytoplasm. To confirm this hypothesis, the intracellular distribution of GFP-TR$ was studied after treatment with sodium azide, which depletes intracellular stores of ATP and previously has been shown to block the ATP-dependent uptake of both the estrogen and progesterone receptors into the nucleus (29) .
After a two hour treatment with sodium azide, approximately 10% of the nuclear localized GFP-TR$ redistributed to the cytoplasm (Figs. 6A-B, Table 3 ), demonstrating that a subpopulation of GFP-TR$ shuttles between the nucleus and cytoplasm. In addition, treatment of cells with T 3 , either before or after the addition of sodium azide had no effect on the intracellular Table 3 ) demonstrating that the population of GFP-TR$ that shuttles was unaffected by ligand binding. This observation was confirmed by heterokaryon analysis (Fig. 6G ). Here, GFP-TR$ expressing NIH3T3 cells were fused to nonexpressing HeLa cells and GFP-TR$ was found to translocate from the NIH3T3 nuclei to the HeLa nuclei, again confirming that GFP-TR$ can rapidly shuttle between the nuclear and the cytoplasmic compartments.
These findings suggested that nuclear import of both the unliganded and liganded TR$ was an energy-dependent process. In further support of this point, the effect of sodium azide on GFP-TR$-AHT was studied. In the presence of sodium azide, a significant redistribution of this receptor was observed, with ~ 50% of the nuclear-localized GFP-TR$-AHT redistributing to the cytoplasm ( Table 3) . As shown above, addition of ligand to GFP-TR$-AHT led to a 15 redistribution of the receptor from the cytoplasm to the nucleus (Figs. 4A-B, Table 2 ). However in the presence of sodium azide, this nuclear translocation was blocked (Table 3) , again demonstrating that nuclear import of TR$ is an ATP-dependent process.
As described above (Figs. 4-5, Table 2 Previous experiments with the estrogen receptor found that the ligand-bound ER is in a tighter association with the nucleus than the unliganded receptor (27, 34) . We have found very similar results with TR$. In both the absence (Fig. 7A ) and presence ( Fig. 7B ) of ligand, high salt and detergent extractions of GFP-TR$ expressing cells failed to remove all of the receptor from the nuclei, indicating that the receptor was tightly associated with one or more factors within the nucleus. However, after DNase and ammonium sulfate treatment to remove the chromatin, the unliganded GFP-TR$ was completely lost from the nucleus, whereas a portion of the liganded GFP-TR$ remained associated with an extraction-resistant component of the nucleus (Fig. 7B bottom panel, data not shown). Therefore, ligand binding not only induces a change in the intranuclear distribution of TR$ but also increases the association of the receptor with nonchromatin components of the nucleus.
Discussion
Nuclear receptors can be divided into three broad categories, based on their unliganded distributions: those that are primarily nuclear [estrogen receptor (27, 35, 36) and TR$ (23,our results)], those that are primarily cytoplasmic [glucocorticoid receptor (8, 10, 37) and androgen receptor (13)] and those with a mixed distribution [mineralocorticoid receptor (38) and progesterone receptor (11, 12) ]. However, in all cases, addition of ligand leads to a near complete nuclear localization of the receptors [reviewed in (39) ]. Thus it is possible there may be a continuum of cellular/nuclear distributions among the unliganded nuclear hormone receptors that plays a role in modulating their activity in both the absence and presence of ligand.
We have used fluorescence microscopy in conjunction with GFP fusion proteins to 
Thus, TR$/RXR/N-CoR may form a complex that maintains TR$ in the nucleus and increases
basal repression (Fig. 8 ).
In conjunction with our preceding data, we propose a model of TR$ intracellular distribution in which a subpopulation of the receptor is continually shuttling between the cytoplasm and nucleus. This continual shuttling results in a dynamic equilibrium between the by guest on http://www.jbc.org/ Downloaded from rate of ATP-dependent nuclear import and passive nuclear export (Fig. 8) . The observed nuclear localization of GFP-TR$ results when the rate of nuclear import exceeds that of nuclear export.
Nuclear proteins, such as RXR and N-CoR interact with the nuclear localized TR$, decrease the rate of nuclear export and alter the equilibrium of the receptor. Since GFP-TR$-AHT cannot interact with N-CoR, the rate of nuclear export increases, and the observed intracellular 
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The current model views unliganded TR$ as statically bound to TREs and actively involved in basal repression of positively-regulated genes through corepressor interactions (19, 48) . Upon addition of T 3 , the corepressors are lost and exchanged for coactivators complexes. As a consequence, DNA-binding is thought to be critical for maintaining the unliganded receptor within the nucleus (22) . Therefore, our data showing the predominantly nuclear distribution of GFP-TR$-127 was initially surprising. However, a recent study on the intranuclear dynamics of the glucocorticoid receptor has found that nuclear receptors may not be statically bound to chromatin (49) . Through direct photobleaching studies, it was observed that the glucocorticoid receptor is not statically bound to chromatin but instead is rapidly exchanging between chromatin and the nucleoplasm. Based on these results, it is reasonable to speculate that the unliganded TR$ may also be rapidly exchanging between chromatin and the nucleoplasm. If so, then DNA-binding would not be a critical factor in maintaining TR$ within the nucleus.
A central tenet of the current TR$ models is that the receptor remains bound to the same chromatin response element when ligand is added and the differential activity of the receptors with and without ligand results from the different macromolecular complexes that interact with the ligand-free and ligand-bound receptors. However, we have observed an intranuclear reorganization of TR$ in the presence of T 3 , suggesting that a significant pool of the receptor is moving from one site to another in response to ligand. Similar ligand-dependent intranuclear distributions have been observed for other nuclear hormone receptors, including the estrogen receptor, glucocorticoid receptor, mineralocorticoid receptor and androgen receptor (8, 34, 50, 51) .
Therefore, ligand-bound nuclear receptors may adopt similar intranuclear distributions, though 21 the exact nature of these nuclear substructures is still a matter of debate. Our studies with high salt, detergent-extracted and DNase-treated, nuclei suggest that a significant portion of liganded TR$ can interact with nuclear components other than chromatin, whereas unliganded TR$ cannot. Similar results have been reported for other nuclear receptors including ER and GR (27, 52) . Therefore, the intranuclear redistribution of these receptors appears to recruit the receptors to an insoluble component of the nuclear substructure. Why then would the liganded nuclear receptors be resistant to DNase treatment? One possibility is that in addition to being bound to DNA, the liganded nuclear receptors interact with other nuclear substructures and it is these interactions that instill the DNase insensitivity to their distribution. A second possibility is that the DNase insensitive receptors represent a subpopulation of liganded receptors that are, for one reason or another, inactive. Previous observations have found that the ligand-bound forms of several nuclear receptors, including the estrogen, progesterone, and retinoic acid receptors are rapidly degraded by the 26S proteasome (53) (54) (55) (56) (57) . Therefore, it is intriguing to speculate that the DNase resistant forms of TR$ and of the other nuclear receptors may represent a population of receptors that are currently being degraded or are targeted for degradation by the proteasome.
In summary, we have observed nuclear/cytoplasmic shuttling of TR$ in living cells using GFP technology. We also have observed that T 3 promotes nuclear redistribution of TR$.
Additionally, we have shown that TR$ can localize in the nucleus even in the absence of ligandor DNA-binding. Furthermore, RXR and N-CoR may promote this nuclear localization in the absence of ligand. We speculate that nuclear/cytoplasmic shuttling may be a novel mechanism for modulating transcription by TR$ and other nuclear hormone receptors. Understanding how 
